# NIAID DAIT CLINICAL PRODUCTS CENTER (CPC) for Studies of Radiation/Nuclear Countermeasures Research

> **NIH NIH N01** · — · 2022 · $1,093,081

## Abstract

The Clinical Product Center under contract, provides Investigational Product Services for all DAIT-funded and/or sponsored clinical research programs and other NIAID-funded clinical trials as needed. Studies to be supported include radiation/nuclear countermeasures research. Additionally, and on an as-needed basis, clinical trials of infectious disease treatment, prevention and other vaccine studies. Investigational Products to be studied include schedule I through VI pharmaceutical agents, biologics, and other agents.

## Key facts

- **NIH application ID:** 10672843
- **Project number:** 75N93019C00003-P00008-9999-4
- **Recipient organization:** —
- **Principal Investigator:** ANBU DEVASAHAYAM
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,093,081
- **Award type:** —
- **Project period:** 2019-04-01 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10672843

## Citation

> US National Institutes of Health, RePORTER application 10672843, NIAID DAIT CLINICAL PRODUCTS CENTER (CPC) for Studies of Radiation/Nuclear Countermeasures Research (75N93019C00003-P00008-9999-4). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10672843. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*